- KFF Health News Original Stories 2
- Many People With Disabilities Risk Losing Their Medicaid if They Work Too Much
- Bill That Congressman Says Protects Medicaid Doesn’t — And Would Likely Require Cutting It
- Political Cartoon: 'Crash Test Insurance?'
From KFF Health News - Latest Stories:
KFF Health News Original Stories
Many People With Disabilities Risk Losing Their Medicaid if They Work Too Much
As politicians demand that more Medicaid recipients work, many people with disabilities say their state programs’ income and asset caps force them to limit their work hours or turn down promotions. (Tony Leys, 3/25)
Bill That Congressman Says Protects Medicaid Doesn’t — And Would Likely Require Cutting It
U.S. Rep. Nick LaLota, a Long Island Republican, told his constituents that he voted for the House-passed GOP budget resolution because it protects Medicaid, Medicare, and Social Security. However, the bill charges a committee with making cuts that likely can’t be attained without slashing Medicaid. (Julie Appleby, 3/25)
Political Cartoon: 'Crash Test Insurance?'
KFF Health News provides a fresh take on health policy developments with "Political Cartoon: 'Crash Test Insurance?'" by Larry Lambert.
Here's today's health policy haiku:
HELP FOR HOARDING
Boomers: Fight the blight!
Support group plus friendship helps.
Age safely at home.
- Anonymous
If you have a health policy haiku to share, please Contact Us and let us know if we can include your name. Haikus follow the format of 5-7-5 syllables. We give extra brownie points if you link back to an original story.
Opinions expressed in haikus and cartoons are solely the author's and do not reflect the opinions of KFF Health News or KFF.
We’d like to speak with personnel from the Department of Health and Human Services or its component agencies about what’s happening within the federal health bureaucracy. Please message us on Signal at (415) 519-8778 or get in touch here.
Summaries Of The News:
Acting Chief Susan Monarez, Who Is Not A Physician, Tapped To Lead CDC
The biosecurity expert has degrees in microbiology and previously served as deputy director of ARPA-H. For the first time, the post will require Senate confirmation, following a law change in 2022.
Stat:
Trump Picks Susan Monarez To Run The CDC
After the chaotic withdrawal of President Trump’s previous nominee to lead the Centers for Disease Control and Prevention, the president selected the CDC’s acting director, Susan Monarez, to lead the agency. Monarez would be the first CDC director since 1953 not to have a medical degree. She has a B.S. and Ph.D. in microbiology from the University of Wisconsin-Madison. (Owermohle and Branswell, 3/24)
Newsweek:
Who Is Dr. Susan Monarez? Donald Trump's Pick To Lead CDC
Susan Monarez has previously held several prominent positions within the U.S. government. She served as deputy director of the Advanced Research Projects Agency for Health (ARPA-H), where she led initiatives in artificial intelligence and health technology. She has also held roles at the Department of Homeland Security and the White House Office of Science and Technology Policy. This nomination is notable as Monarez would be the first CDC director to require Senate confirmation, following a law change in 2022. (Whisnant and Adeosun, 3/24)
Feds Scrapping Office That Researched, Coordinated Response To Long Covid
The health care system could wind up providing long and costly care for Americans plagued by lingering effects of a covid infection, one HHS staffer warns. An estimated 23 million people have long covid.
Politico:
Trump Administration Shuttering Long Covid Office
The Trump administration is shuttering HHS’ long Covid office as part of its reorganization, according to an internal email seen by POLITICO. The email was sent Monday by Ian Simon, the head of the Office of Long Covid Research and Practice. It said the closing is part of the Department of Health and Human Services’ reorganization. (Gardner and Ollstein, 3/24)
More from the Trump administration —
Stat:
NIH Removing Outside Scientific Advisers Who Evaluate Research
Prominent outside scientists who help the National Institutes of Health evaluate its internal research programs are being abruptly removed, according to five advisers whose positions were terminated and a recording of an internal meeting obtained by STAT. (Molteni and Mast, 3/24)
The Wall Street Journal:
Trump Administration Asks Supreme Court To Block Order Reinstating Federal Employees
The Justice Department asked the Supreme Court on Monday to block a judge’s order requiring it to reinstate more than 16,000 federal employees, as administration officials vow to seek the justices’ intervention in clearing away lower-court rulings that have slowed Trump policies. In her Supreme Court brief, acting Solicitor General Sarah Harris argues that the case should have been thrown out of court because it was filed by labor unions and other organizations rather than the terminated employees themselves. (Bravin, 3/24)
ProPublica:
NIH Ends Funding To Study The Health Effects Of Climate Change
The National Institutes of Health will no longer be funding work on the health effects of climate change, according to internal records reviewed by ProPublica. The guidance, which was distributed to several staffers last week, comes on the back of multiple new directives to cut off NIH funding to grants that are focused on subjects that are viewed as conflicting with the Trump administration’s priorities, such as gender identity, LGBTQ+ issues, vaccine hesitancy, and diversity, equity and inclusion. (Waldman and Lerner, 3/24)
Axios:
The Trump Administration Wants More Studies Replicated. That Won't Be Easy
The Trump administration wants to spend more federal dollars replicating medical research. A key question will be which studies get repeated and, with limited resources, at what expense. Many findings can't be replicated — a problem scientists say needs to be addressed. But it could also consume increasingly scarce resources as the administration cuts spending and freezes federal grants. (Snyder, 3/24)
The Washington Post:
European Universities Compete To Poach Top U.S. Scientists
Europe is investing millions in a flurry of newly announced academic programs, in an energetic effort to lure top American scientists across the Atlantic at the same time as President Donald Trump casts many U.S. research efforts into turmoil with funding cuts and executive edicts. Spurred by “alarming political interference in academic research by the Trump administration,” Brussels’s Vrije Universiteit (VUB), or Free University, allocated $2.7 million in funding last week for at least 12 new postdoctoral roles open to “censored Americans.” (Sands, 3/24)
On veterans' health care —
Military.com:
As Pentagon's Top Health Nominee Prepares For Confirmation Hearing, One Senator Has A Lot Of Questions
Ahead of his confirmation hearing Thursday to become assistant secretary of defense for health affairs, Keith Bass is facing tough questions from a prominent Democrat on the Senate Armed Services Committee. Bass, a retired Navy commander and substance abuse counselor who previously led the Central Intelligence Agency's Office of Medical Services and the White House Medical Unit, was nominated Dec. 22 to manage the Defense Department's $61 billion health system, which serves 9.5 million beneficiaries, including 1.3 million active-duty troops. (Kime, 3/24)
The Philadelphia Inquirer:
A Federal Judge Blocks Trump Administration From Moving To Fire 2 Transgender Air Force Members
A federal judge on Monday agreed to temporarily block President Donald Trump's administration from initiating proceedings that could lead to the firing of two transgender men serving in the U.S. Air Force — the latest legal setback in the administration's push to implement sweeping changes in the military. The decision by U.S. District Judge Christine P. O'Hearn came less than a week after the men — Master Sgt. Logan Ireland and Staff Sgt. Nicholas Bear Bade — sued to try to prevent their impending dismissal under Trump's executive order seeking to bar transgender people from serving in the military. They filed suit in New Jersey because Bade is stationed at Joint Base McGuire-Dix-Lakehurst in Burlington County, and Ireland recently was stationed there for a training program. (Palmer, 3/24)
Military.com:
Families At Utah Air Force Base Lose Day Care Center As Pentagon Slashes Personnel Spending
Hill Air Force Base in Utah -- the service's second-largest base by population and size -- has closed one of its two day care centers, harming quality of life for some service members, civilian employees and their families following hiring freezes ordered by President Donald Trump's administration. (Novelly, 3/24)
23AndMe Users Rush To Remove Genetic Information After Bankruptcy
Customers concerned about privacy attempted to delete their data but struggled to receive deletion confirmation, The Wall Street Journal reported. In other news: the FDA approves a lab-grown blood vessel; UK drugmaker GSK Plc is studying its shingles vaccine for expanded use as dementia prevention; and more.
The Wall Street Journal:
23andMe Customers Scramble To Delete Data, Seek Assurances After Bankruptcy
An array of 23andMe ME customers rushed to its website Monday, seeking to delete their genetic data from the DNA-testing company after its bankruptcy filing. They faced long wait times or error messages and had to make repeated attempts to receive confirmation that their request had been received. Some sought unsuccessfully to delete the data of a deceased family member, and many expressed uncertainty about whether or how they would receive confirmation that the data had been deleted. (McElhaney, 3/24)
CBS News:
Here's How To Delete Your Personal Data And Genetic Sample From 23andMe
23andMe states that if it's involved in a bankruptcy or sale, customers' personal data may also be sold or transferred. It also provides a relatively straightforward way for customers to delete their data and request that their genetic samples be destroyed. (Cerullo, 3/24)
More pharma and tech news —
The New York Times:
FDA Approved Artificial Blood Vessel Despite Warnings
When the biotech company Humacyte designed a study to see if its lab-grown blood vessel worked, it decided to measure whether blood was flowing freely through the high-tech tube 30 days after it was implanted in a person. As those days passed, some of the 54 patients in the study ran into trouble. Doctors lost track of one. Four died. Four more had a limb amputated, including one who developed a clot and infection in the artificial vessel, Food and Drug Administration records show. (Jewett, 3/24)
Modern Healthcare:
Fujifilm, Us2.Ai Partner To Automate Cardiovascular Ultrasound
Fujifilm Healthcare Americas Corporation said Monday it will integrate Us2.ai's artificial intelligence software into its Lisendo 800 cardiovascular ultrasound. The software automates echocardiogram analysis and reporting by providing cardiac measurements along with diagnostic insights based on international guidelines. (Dubinsky, 3/24)
The Guardian:
Scientists Develop Injection For Long-Lasting Contraceptive Implant
Researchers are developing an injection that creates a contraceptive implant in the body using an approach that could herald a new way of delivering drugs over long periods of time. Current contraceptive implants last for years, meaning women do not have to take a pill every day, but the devices must be fitted by a trained professional via a small surgical procedure. Contraceptive injections are already available but they have limitations, including that they last for only three months. Now scientists say they have completed proof-of-concept experiments for a new type of long-lasting implant that self-assembles in the body. (Davis, 3/24)
Bloomberg:
GSK Researching Whether Shingles Vaccine Reduces Dementia Risk
GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for the shot. The UK drugmaker will look at the data of 1.4 million people aged 65 to 66 years, some of whom received GSK’s Shingrix shot and some who did not, over a four-year period starting from 2023. (Furlong, 3/25)
Stat:
Cell And Gene Therapies Have Seen Setbacks — But Are Still Promising
The sale of bluebird bio and Pfizer’s decision to drop a gene therapy for hemophilia have led to some anxiety regarding the future of cell and gene therapy (CGT). As the chief executive officer of the nonprofit multistakeholder advocacy organization the Alliance for Regenerative Medicine, I hear all the questions: Will the technology meet the promise? Is there a viable commercial model in one-time treatments? Is there a sustainable business that can scale? I remind people that the reality is a bit messy — but a highly familiar tale of breakthroughs and struggles in the bigger arc of biotechnology. (Tim Hunt, 3/25)
Supreme Court Case Involving Planned Parenthood Could Wreck Medicaid
The case asks the Supreme Court to render much of federal law unenforceable, in an attempt to hurt abortion providers, Vox reports. In other Medicaid news: CDPAP program extends enrollment period; Ohio Medicaid delays confirmed by providers despite denial by state officials; and more.
Vox:
The Supreme Court’s New Abortion Case Could Destroy Medicaid
Kerr v. Planned Parenthood South Atlantic is one of the most straightforward cases the Supreme Court will hear this year. It involves a federal law that requires every state’s Medicaid program to ensure that “any individual eligible for medical assistance” may obtain that care “from any institution, agency, community pharmacy, or person, qualified to perform the service or services required.” Thus, Medicaid patients, and not the state, clearly have a right to choose their own health providers, with only one exception. The provider must be “qualified,” which, as the federal appeals court that heard this case explained, means that the provider is “professionally competent” to provide the care that the patient seeks. (Millhiser, 3/25)
In other Medicaid news —
Politico:
State Implements Grace Period For CDPAP Participants
Consumers who have failed to complete registration for the Medicaid program known as CDPAP by April 1 will be allowed to continue their services and workers until April 30. Those who enroll during the grace period will be eligible to receive retroactive payments, the state Department of Health revealed to POLITICO on Sunday. The late registration window extends until April 30, but the Hochul administration says this is not a delay: It’s merely a safeguard to ensure that participants in the popular Medicaid program don’t lose service. (Cordero and Kaufman, 3/24)
WVXU:
State Officials Deny Issues With Ohio Medicaid, As Health Providers Confirm Delayed Payments
Ohio Medicaid changed the way it processes claims for payments from health providers a few years ago. And now it appears it's taking longer for those providers to get paid. Although the agency denies it's a problem, two large central Ohio hospital systems confirm they've experienced the delays. (Fox, 3/24)
KFF Health News:
Many People With Disabilities Risk Losing Their Medicaid If They Work Too Much
Zach Mecham has heard politicians demand that Medicaid recipients work or lose their benefits. He also has run into a jumble of Medicaid rules that effectively prevent many people with disabilities from holding full-time jobs. “Which is it? Do you want us to work or not?” he said. Mecham, 31, relies on the public insurance program to pay for services that help him live on his own despite a disability caused by muscular dystrophy. (Leys, 3/25)
KFF Health News:
Bill That Congressman Says Protects Medicaid Doesn’t — And Would Likely Require Cutting It
On Feb. 25, Rep. Nick LaLota (R-N.Y.) voted in favor of a House budget resolution that calls for sharp cuts in spending across a vast array of government areas. Medicaid is among the programs that could be at risk — catapulting it to the center of the political debate. President Donald Trump has insisted he won’t harm Medicaid, Medicare, and Social Security benefits, saying his administration is looking to root out fraud. But Democrats have pushed back, saying the sheer size of the proposed cuts will result in harm to the Medicaid program, its enrollees, and medical providers. (Appleby, 3/25)
The Wall Street Journal:
Who Medicaid Cuts Would Affect The Most, In 5 Charts
The program is a political flashpoint because of its vital role in the lives of adults and children across the country. (Mathews and Overberg, 3/24)
West Virginia Becomes First State To Ban Virtually All Artificial Food Dyes
Although the legislation will go into effect in 2028, school meals will not be allowed to have the dyes beginning in August. In other news: HHS Chief RFK Jr. lays out his plan to ensure the safety of baby formula; soda companies push to remain covered by food stamps; and more.
The New York Times:
West Virginia Bans 7 Artificial Food Dyes, Citing Health Concerns
In the most sweeping move of its kind, West Virginia has banned foods containing most artificial food dyes and two preservatives, citing their potential health risks. The legislation, signed into law Monday by Gov. Patrick Morrisey, will go into effect in 2028. At least 20 states are considering similar restrictions on food chemicals, but West Virginia is the first to ban virtually all artificial dyes from foods sold statewide. The new law will also prohibit products containing the dyes from being served in school meals starting this August. (Callahan, 3/24)
In related news about 'MAHA' and RFK Jr. —
The New York Times:
Washington Bends To RFK Jr.’s ‘MAHA’ Agenda On Measles, Baby Formula And French Fries
Public health leaders are horrified by Robert F. Kennedy Jr.’s approach to measles, but government and industry are responding to him. (Stolberg, 3/25)
The 19th:
What RFK Jr.’s Plans For Baby Formula Safety Mean For Parents
Federal officials earlier this month announced a new initiative that they say will better ensure the safety and nutrition of baby formula in America, a directive that puts a spotlight on the current state of formula production and oversight — and may raise questions for some parents about which products they should buy to feed their young children. (Rodriguez, 3/24)
The Washington Examiner:
Soda Companies Resist MAHA Effort To Cut Them Out Of Food Stamps
Large soda companies are worried about their futures as Republicans eye legislation to exclude sugary drinks from SNAP, also known as food stamps. (Green and Halashak, 3/25)
On hunger and nutrition —
KSL TV:
‘It’s Devastating’: Hundreds Of Utahns Are Experiencing Food Stamp Theft Every Month
Thousands of Utahns have been the target of online hackers over the last several months, according to data provided by the Utah Department of Workforce Services. As of December, federal funds set aside to reimburse stolen benefits have run out and the state has not stepped in to fund reimbursements. (Rivera, 3/21)
NBC News:
Healthy Eating Increases Odds Of Reaching 70 Without Chronic Disease, Study Says
Following a healthy diet — one primarily plant-based, with minimal ultra-processed food and low to moderate amounts of animal-based foods like fish and dairy — can raise the chances of reaching age 70 without developing a chronic disease, according to a new study. The research, published Monday in the journal Nature Medicine, analyzed the diets of more than 105,000 people in midlife and found that by 70, less than 10% had achieved “healthy aging.” (Bendix, 3/24)
MedPage Today:
Longer Breastfeeding May Reduce Developmental Delays In Kids
Breastfeeding exclusively and for longer duration were independently associated with reduced odds of developmental delays and some neurodevelopmental conditions, according to a retrospective study from Israel. Children who were exclusively breastfed, along with those breastfed for at least 6 months had fewer delays in reaching language and social or motor developmental milestones versus children breastfed for less than 6 months, reported Inbal Goldshtein, PhD, of the KI Research Institute in Kfar Malal, and colleagues. (Robertson, 3/24)
More Health Care Leaders Plan To Leave Jobs This Year, Survey Shows
The number of people in leadership positions willing to leave within the next 12 months rose by five percentage points when compared with last year's figures. Other industry news includes management cuts at Yale New Haven Health; health systems responding to anti-DEI efforts; and more.
Modern Healthcare:
AMN Healthcare Survey Finds Managers, Executives Ready To Leave
More healthcare leaders are planning to leave their organizations in the next year, according to a survey from B.E. Smith, a member of staffing group AMN Healthcare, which focuses on leadership positions. The survey of 588 healthcare leaders, ranging from managers to C-suite executives, shows that 46% of respondents intend to leave their organizations within the next 12 months, compared with 41% in 2024. (DeSilva, 3/24)
Modern Healthcare:
Yale New Haven Health Restructures, Cuts Management Roles
Yale New Haven Health is restructuring operations and consolidating management and administrative roles. The restructure will affect inpatient and ambulatory operations. Most of the affected employees will be transitioned to new roles at Yale New Haven, but up to 38 people could be laid off from the health system, Director of Public Relations Dana Marnane said in a statement. (Hudson, 3/24)
Modern Healthcare:
How HCA, Tenet, Providence Are Responding To Anti-DEI Efforts
Health systems are trying to steer clear of the Trump administration as it targets diversity, equity and inclusion initiatives. Some providers are removing DEI language from their annual reports, rethinking titles for leaders and updating programs. Others are still assessing their response. There may not be one right answer, particularly for healthcare, which finds itself particularly reliant on federal funding. (Hudson, 3/24)
News Service of Florida:
FSU Is Pursuing A Plan To Fund And Build A Hospital In Panama City Beach
Pointing to opportunities to conduct research and serve an aging population, Florida State University this week will seek approval to issue $413.9 million in bonds to build a hospital in Panama City Beach. The State University System’s Board of Governors will be asked Wednesday to sign off on the bonds, after the Florida State University Board of Trustees meets earlier in the day on the issue. (Saunders, 3/24)
Health News Florida:
Match Day For Jacksonville Med Students Illuminates Florida's Gap In Producing New Doctors
The third Friday in March is when med school grads learn where they will start their careers as residents. Often they extend their careers in the same area, although Florida trails other large states in such retention. (Brown, 3/24)
MedPage Today:
Greater NICU Capacity Hasn't Lowered Infant Mortality, Study Finds
Rising neonatal intensive care unit (NICU) capacity was not tied to lower infant mortality, a large cross-sectional study in the U.S. suggested. From 1991 to 2020, total adjusted neonatologists per 1,000 live births increased 227%, from 0.44 to 1.44, while NICU beds per 1,000 live births rose 48%, from 5.43 to 8.02, respectively, reported researchers led by Gwenyth Gasper, MS, of the Geisel School of Medicine at Dartmouth in Hanover, New Hampshire. (Henderson, 3/24)
Tennessee Logs First Measles Case Of 2025
It is unclear how the person was exposed to the virus, officials say. Meanwhile, experts warn air travel may lead to more imported cases. Other news is on dengue fever outbreaks in popular spring break destinations; New York City's mental health programs; and more.
CIDRAP:
Tennessee Confirms First Measles Case Of The Year
Tennessee has reported its first measles case of the year, in a mid-state resident whose exposure is still under investigation, according to the Tennessee Department of Health (TDH). (Soucheray, 3/24)
Related news about measles and dengue —
CNN:
‘Measles Is Only A Plane Flight Away’: As Outbreak Surges, Experts Warn Against Global Health Funding Cuts
After returning home from a trip abroad last week, an infant in Houston was hospitalized with measles. In Lamoille County, Vermont, this month, a child became sick with measles after returning from foreign travel. The same thing happened to an adult in Oakland County, Michigan, whose vaccination status was unknown. Although measles was declared eliminated in the United States in 2000, it still rages on in many parts of the world. With decreasing vaccination rates across the US, experts say, imported cases can have large consequences. (Mikherjee, 3/24)
Fox News:
Dengue Fever Cases Rising In Popular Spring Break Locations, CDC Alerts
As spring breakers this season continue to head south into warmer territory, mosquitoes are posing a health risk that calls for extra attention. The following countries have also reported higher-than-expected numbers of dengue cases among American travelers returning to U.S. soil: Brazil, Burkina Faso, Colombia, Cuba, Ecuador, Fiji, French Polynesia, Guadeloupe, Guatemala, Iran, Mexico, Pakistan, Panama, Philippines, Saint Lucia and Sudan. (Stabile, 3/24)
More health news from across the U.S. —
CBS News:
NYC Mental Health Program Pushed By Adams In Doubt After Report Questions Effectiveness
One of New York City Mayor Eric Adams' signature mental health programs is in question after a City Council report suggested sending mentally ill people who are homeless to involuntary care has been ineffective. Members were never happy with Adams' decision to force the severely mentally ill into treatment against their will, but their report comes as the mayor says he's gearing up to run for reelection and wants to tout his accomplishments. (Kramer, 3/24)
Charlotte Ledger:
Turf War Erupts Over Organ Donation Services
A lawsuit filed earlier this month seeks to stop Atrium Health from taking control of organ donation services at partner hospital Wake Forest Baptist Medical Center in Winston-Salem. For 40 years, Wake Forest Baptist relied on HonorBridge, an independent organ procurement organization that serves 75 percent of North Carolina, to handle the hospital’s life-saving organ donations and get them to transplant recipients. But after joining the Atrium Health system, Wake Forest Baptist petitioned the federal government to switch to LifeShare Carolinas, Atrium’s in-house organ procurement service. (Crouch, 3/25)
CBS News:
New Colorado Health Science High School In Aurora To Bridge The Health Care Workforce Gap
Aurora Public Schools is partnering with Community College of Aurora to launch the state's first health science high school. Aurora voters approved a bond in 2024 that will fund the project. The school will prepare students for careers in health care and address the growing demand for health care workers. The magnet school, which doesn't have a name yet, will give students a head start in the workforce by offering hands-on experiences and college-level courses. (Mason, 3/24)
Politico:
When Will California See The Money Prop 35 Promised?
The powerful health care interests who put Proposition 35 on the ballot last November had a simple pitch for the complex initiative: a tax no voter paid would provide a long-awaited pay bump to doctors and hospitals who serve the state’s lowest-income residents. Californians overwhelmingly accepted the offer, giving Prop 35 more than two-thirds of the vote, but are no closer to seeing the changes they were promised. (Bluth, Schultheis and McCarthy, 3/24)
Bayer Directed To Pay Cancer Patient Nearly $2.1 Billion In Roundup Case
A Georgia man maintains two decades of using the weedkiller caused his cancer. Also in the news: prostate cancer, breast cancer, and cancer research funding cuts.
The Hill:
Monsanto Parent Ordered To Pay $2B In Roundup Lawsuit Damages
The company behind Roundup weedkiller herbicide was ordered to pay more than $2 billion in a man’s cancer lawsuit. According to his attorneys, John Barnes developed non-Hodgkin’s lymphoma after using Monsanto’s Roundup for two decades. The case resulted in a $2.065 billion verdict, Barnes’s lawyers said. The Associated Press reported that Bayer, the parent company for Monsanto, was ordered to pay $65 million to compensate Barnes and an additional $2 billion in punitive damages by a Georgia jury. Monsanto is appealing the ruling. (Frazin, 3/24)
In cancer research —
The Guardian:
Prostate Cancer Surgery Breakthrough Offers Hope For Erectile Function
A more precise form of prostate cancer surgery nearly doubles the chances of men retaining erectile function afterwards compared with standard surgery, according to the first comprehensive trial of the procedure. Doctors in five UK hospitals assessed the surgical approach that aims to preserve crucial nerves that run through the outer layer of the prostate and are thought to be responsible for producing erections. (Sample, 3/24)
Fox News:
Men Who Avoid Prostate Cancer Screening Appointments Face Much Higher Risk Of Disease
Researchers are warning that men who regularly dodge prostate cancer screening appointments are 45% more likely to die from the disease. Prostate cancer is the most common cancer among men and the second-leading cause of cancer deaths, according to UC San Francisco (UCSF). (Rudy, 3/22)
Medical Xpress:
Delay Of More Than 42 Days For Breast Cancer Surgery Raises Death Risk For Certain Subtypes, Study Finds
Patients with certain subtypes of breast cancer may face a higher risk of death from the cancer if they wait more than 42 days after diagnosis to have surgery, according to newly published research from the University of Oklahoma. The research team was surprised that the subtypes of breast cancer most affected by delayed surgery were those with the best prognosis: hormone receptor-positive breast cancers, meaning the cancer uses estrogen or progesterone to grow, and HER2-negative cancers, which do not have high levels of the HER2 protein that is associated with more aggressive cancer growth. (3/24)
Stat:
Cancer Research, Long Protected, Feels ‘Devastating’ Effects Under Trump
Mark Vieth was stunned when he saw the numbers. Vieth coordinates the Defense Health Research Consortium, which advocates for a Pentagon program that has long received about $1.5 billion a year in federal funds for medical research — nearly half of which typically goes toward cancer. (Chen, 3/24)
Editorial writers examine these public health issues.
The Washington Post:
Ambient AI Is About To Make Your Doctor’s Visit Much Better
The technology, which uses a smartphone app to “listen” to clinical encounters (with the patient’s consent) and convert the conversation into medical documentation, is transforming care for the better. Health systems and federal regulators should look to this example of how artificial intelligence that reduces administrative inefficiencies can vastly improve the care experience. (Leana S. Wen, 3/25)
Stat:
The High Cost Of Cutting Medicaid Services For People With Dementia
In April 1990, in testimony to the joint congressional hearing titled “Alzheimer’s – The Unmet Challenge for Research and Care,” Hilda Pridgeon, a founder of the Alzheimer’s Association, recounted the challenges of working full-time for Control Data Corporation and caring for her husband, Al, who was living with dementia. The American health care system offered them no support. (Jason Karlawish, 3/25)
The New York Times:
Human Embryo Research: What Time Limit Should We Set?
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of my fertilized eggs had made it to the five-day-old blastocyst stage. (Anna Louie Sussman, 3/25)
The CT Mirror:
Uncertainty Harms Public Health
A few days ago, I spoke with “Lisa” who is a participant in a research study at the Yale School of Public Health. Lisa, a New Haven resident, has spent almost five years on a subsidized housing waitlist. Since losing her apartment early in the pandemic, Lisa has stayed on a relative’s couch anxiously awaiting rental assistance that would help her to afford her own apartment. Unfortunately, such subsidies are in short supply. (Penelope Schlesinger, 3/25)
The Washington Post:
End Experiments On Dogs
Every year, more than 50,000 dogs, mostly beagles, are used in research in the United States. They are often used in painful and deadly tests, and laws to protect them are minimal. We should end this betrayal of man’s best friend. (Mark Bekoff and Jane Goodall, 3/24)